Nephrology
An update on refractory hypertension.
24 Jun, 2022 | 11:44h | UTCAn Update on Refractory Hypertension – Current Hypertension Reports
Hemorrhagic fever with renal syndrome: literature review, epidemiology, clinical picture and pathogenesis.
24 Jun, 2022 | 11:02h | UTC
Onconephrology: Update in anticancer drug-related nephrotoxicity.
21 Jun, 2022 | 10:47h | UTCOnconephrology: Update in Anticancer Drug-Related Nephrotoxicity – Nephron
Related:
Commentary from the author on Twitter
Just published! Our review about anticancer drugs related kidney injury with @PepaSolerR and @julianadraibe @SENefrologia @onconephsociety @onconefrologia @senjoven @ERAkidney @womeninnephro https://t.co/jFStKwym5z @KargerPublisher pic.twitter.com/zvbl7wxAbD
— Clara García Carro (@ClaraGCarro) June 20, 2022
Consensus Recommendations: Management of the congenital solitary kidney.
20 Jun, 2022 | 01:25h | UTC
AHA Scientific Statement: Revascularization for renovascular disease.
17 Jun, 2022 | 11:50h | UTCTop Things to Know: Revascularization for Renovascular Disease – American Heart Association
Commentary: When is Renovascular Hypertension Amenable to Revascularization – American Heart Association
Review: Sepsis management for the nephrologist.
15 Jun, 2022 | 11:23h | UTCSepsis Management for the Nephrologist – Clinical Journal of the American Society of Nephrology
Systematic Review: Regional citrate anticoagulation and systemic anticoagulation during pediatric continuous renal replacement therapy.
15 Jun, 2022 | 10:27h | UTC
Systematic Review: Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis.
14 Jun, 2022 | 10:33h | UTC
Guidelines for the management of hypertension.
13 Jun, 2022 | 08:13h | UTC
Position Statement: Management of diabetic kidney disease.
13 Jun, 2022 | 08:09h | UTC
SGLT2 inhibitor reduces the risk of hyperkalemia in patients with heart failure.
13 Jun, 2022 | 07:52h | UTCEditorial: Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure
Commentary on Twitter
More evidence that SGLT2i ⬇️ hyperK, this time in heart failure
Empagliflozin reduces:
– K>6.0: HR 0.62 95% CI 0.48–0.81
– Investigator reported hyperK or K binders, HR 0.82 95% CI 0.71-0.95
– Effect modified by GFR – larger in CKD
– Regardless of MRAshttps://t.co/t4T7II1G8p pic.twitter.com/RP1EUKXHyV— Brendon Neuen (@brendonneuen) June 12, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Association of estimated GFR calculated using race-free equations with kidney failure and mortality by black vs non-black race.
8 Jun, 2022 | 11:12h | UTCEditorial: Race-Free Estimation of Kidney Function: Clearing the Path Toward Kidney Health Equity
Landmark articles suggest eliminating race in the estimation of kidney function.
Expert panel recommends against use of race in assessment of kidney function – STAT
M-A: Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease.
7 Jun, 2022 | 11:25h | UTC
RCT: Effect of perioperative dexmedetomidine on delayed graft function following a donation-after-cardiac-death kidney transplant.
7 Jun, 2022 | 10:55h | UTC
Commentary on Twitter
In this RCT, 24-hour dexmedetomidine infusion, started immediately after induction of & in addition to standard anesthesia, reduced the incidence of delayed graft function vs placebo, following a donation-after-cardiac-death kidney transplantation. https://t.co/cmX1IEZdVX
— JAMA Network Open (@JAMANetworkOpen) June 3, 2022
Guideline: Evaluation and medical management of the kidney stone patient.
2 Jun, 2022 | 11:02h | UTC
Understanding base excess (BE): merits and pitfalls.
1 Jun, 2022 | 11:33h | UTCUnderstanding base excess (BE): merits and pitfalls – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Understanding base excess
🧪 valuable quantitative estimate of metabolic acid-base derangements, but not info on underlying mechanisms
🧪 standard BE composite marker: several components contribute; interpretation of isolated value very difficult#FOAMcc
🖇️https://t.co/T8pcVRrTgR pic.twitter.com/6TEFsFTJR1— Intensive Care Medicine (@yourICM) May 31, 2022
Cohort Study: Intraoperative hypotension is associated with persistent acute kidney disease after noncardiac surgery.
1 Jun, 2022 | 10:53h | UTC
Cohort Study: A multisystem, cardio-renal investigation of post-COVID-19 illness.
31 May, 2022 | 11:44h | UTCA multisystem, cardio-renal investigation of post-COVID-19 illness – Nature Medicine
Commentaries:
Lingering Symptoms After COVID-19 Tied to Heart, Lung, and Kidney Injury – TCTMD
Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome – News Medical
Commentary on Twitter
Deep clinical phenotyping at 28-60 days post-discharge of patients who had been hospitalized with #COVID19 and subsequent long-term follow up with electronic health records reveals evidence of persistent cardio-renal involvement. #postCOVID @ColinBerryMD https://t.co/uLxtj0b1gJ
— Nature Medicine (@NatureMedicine) May 30, 2022
M-A: Risks for donors associated with living kidney donation.
31 May, 2022 | 11:23h | UTCRisks for donors associated with living kidney donation: meta-analysis – British Journal of Surgery
Commentary from the author on Twitter (thread – click for more)
#DiversityAndInclusion 🚺🚹when counseling #Living #Kidney #Donors: our meta-analysis on the #risks stratified according to donor demographic characteristics has just been published @BJSurgery 🔗https://t.co/LtXpPeykiM @MichaelNozdrin @lisetpengel @transplantev 🧵1/7 pic.twitter.com/WszUiTAd1Q
— Maria Irene Bellini MD, PhD, FEBS (@mirenebellini1) May 26, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A: Efficacy of different doses of Daprodustat for anemic non-dialysis patients with chronic kidney disease.
31 May, 2022 | 10:43h | UTCRelated Studies:
Consensus: nephrotoxic potential of 167 drugs in adult critically ill patients.
30 May, 2022 | 11:50h | UTCConsensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method – Drug Safety (if the link is paywalled, try this one)
Review: The role of peritoneal dialysis in different phases of kidney transplantation.
26 May, 2022 | 10:16h | UTCThe Role of Peritoneal Dialysis in Different Phases of Kidney Transplantation – Kidney360
Guidance on contrast associated acute kidney injury.
25 May, 2022 | 11:30h | UTCRelated:
Review: Current and emerging classes of pharmacological agents for the management of hypertension.
24 May, 2022 | 07:47h | UTCCurrent and Emerging Classes of Pharmacological Agents for the Management of Hypertension – American Journal of Cardiovascular Drugs (if the link is paywalled, try this one)
Mechanical circulatory support: primer for nephrology consultants.
24 May, 2022 | 07:38h | UTCRelated:
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art – Critical Care